Trial reportJournal of general internal medicine2018

Quality Improvement and Personalization for Statins: the QUIPS Quality Improvement Randomized Trial of Veterans' Primary Care Statin Use.

Jeremy B Sussman, Robert G Holleman, Bradley Youles, Julie C Lowery

Erratum issued Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of general internal medicine, 2018. The graph read 2 numbers from its abstract, feeding 1 cell of the map: it . An erratum has been issued. It reports registered trial NCT02820870. Cited by 7 papers, 1 of them a synthesis that pooled it.

2numbers the graph read from it
1cell of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

← favours the treatmentfavours the comparator →
241 · no effect
Costs & health-care useno clear difference · head-to-head · ascvdfeeds one cell of the map
OR 1.700.99 to 2.77
KEY RESULTS: Among 3787 visits to 43 primary care providers, being in the intervention arm tripled the odds of patients being prescribed an appropriate statin (OR 3.0, 95% CI 1.8-4.9), though the effect resolved after the personalized decision support ended (OR 1.7, 95% CI 0.99-2.77).
Costs & health-care usefavours the comparator · head-to-head · ascvdfeeds one cell of the map
OR 3.001.80 to 4.90
KEY RESULTS: Among 3787 visits to 43 primary care providers, being in the intervention arm tripled the odds of patients being prescribed an appropriate statin (OR 3.0, 95% CI 1.8-4.9), though the effect resolved after the personalized decision support ended (OR 1.7, 95% CI 0.99-2.77).

clause the extractor read what became the number

2 · Its place on the map

Where it lands on the map

Rows are treatments, columns are outcomes. The coloured squares are the cells this paper feeds, coloured by the vote it casts there. Click one to jump to what this paper adds to it.

supports the treatmentfavours the comparatorno clear differenceread, but no usable result
3 · What it changes

What it adds to each cell

For every cell the paper feeds: the belief in the claim with and without this paper, and this paper's estimate drawn against every other readable study in the cell. The ringed dot is this paper.

Statins×costs & health-care use

No readable resultOpen on the map →What to test next →

1 readable study in this cell: 0 favour the treatment, 0 find no difference, 1 favour the comparator.

Belief with this paper
0.25no deciding trial · 0 families support, 0 contradict · against placebo
Without itNot a counted family in this claim, so removing it changes nothing.
← favours the treatmentfavours the comparator →
1 · no effect
This paper43 enrolled · 2016
OR 3.001.80 to 4.90
4 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02820870 nacompleted

Quality Improvement and Personalization for Statins (QUIPS) (QUE 15-286)

Ran2016Enrolled43Registered outcomes4Posted comparisons2ConditionsCardiovascular DiseaseArmsStatin Decision Support Intervention
Open the trial in the graph
5 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Tailored interventions to address determinants of practice.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
6 · The record

Corrections and comments

7 · Who and what money

Authors and funding

4 authors.

Jeremy B SussmanUniversity of Michigan Department of Internal Medicine, Ann Arbor, MI, USA. jeremysu@med.umich.edu.
Robert G HollemanVA Center for Clinical Management Research, Ann Arbor, MI, USA.
Bradley YoulesVA Center for Clinical Management Research, Ann Arbor, MI, USA.
Julie C LoweryVA Center for Clinical Management Research, Ann Arbor, MI, USA.

Funding

HSRD VA IK2 HX001368
8 · The paper itself

Abstract

The marked sentences are the ones the graph read a number from.

backgroundImplementation of new practice guidelines for statin use was very poor.

objectiveTo test a multi-component quality improvement intervention to encourage use of new guidelines for statin use.

designCluster-randomized, usual-care controlled trial.

participantsThe study population was primary care visits for patients who were recommended statins by the 2013 guidelines, but were not receiving them. We excluded patients who were over 75 years old, or had an ICD9 or ICD10 code for end-stage renal disease, muscle pain, pregnancy, or in vitro fertilization in the 2 years prior to the study visit.

interventionsA novel quality improvement intervention consisting of a personalized decision support tool, an educational program, a performance measure, and an audit and feedback system. Randomization was at the level of the primary care team. MAIN MEASURES: Our primary outcome was prescription of a medium- or high-strength statin. We studied how receiving the intervention changed care during the quality improvement intervention compared to before it and if that change continued after the intervention. KEY

resultsAmong 3787 visits to 43 primary care providers, being in the intervention arm tripled the odds of patients being prescribed an appropriate statin (OR 3.0, 95% CI 1.8-4.9), though the effect resolved after the personalized decision support ended (OR 1.7, 95% CI 0.99-2.77).

conclusionsA simple, personalized quality improvement intervention is promising for enabling the adoption of new guidelines. CLINICALTRIALS. GOV IDENTIFIER: NCT02820870.

Indexed as

VeteransAgedCardiovascular DiseasesCluster AnalysisFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiddle AgedPrecision MedicinePrimary Health CareQuality ImprovementUnited StatesUnited States Department of Veterans AffairsHydroxymethylglutaryl-CoA Reductase Inhibitorscardiovascular diseaseclinical trialsimplementation science

Identifiers

PMID30284172
PMCPMC6258630

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.